|GRANTWAY
EN

Advancing Development of Diagnostics for Congenital and Adult Acquired Syphilis (R21 Clinical Trial Not Allowed)

National Institutes of Health

Share
Favorite
Feedback
Summary
-
02 November 2023
-
-
-
For profit
Not for profit (incl. NGOs)
Public sector
R&D and Higher Education
-
Health, Justice and Social Welfare Research, Development and Innovation
Overview

The purpose of this Notice of Funding Opportunity (NOFO) is to develop new and advance existing diagnostics for congenital and adult acquired syphilis infections by leveraging recent advances in Treponema pallidum basic research and broader infectious disease diagnostic innovations.

Eligibility

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Learn more or apply
All information about this funding has been collected from and belongs to the funding organization
30 June 2023